Press Releases

Dec 05, 2024

Veracyte’s Decipher Prostate Test Is Now the Only Gene Expression Test Recommended in NCCN® Prostate Cancer Guidelines

Read More

Nov 06, 2024

Veracyte Announces Third Quarter 2024 Financial Results

Read More

Oct 30, 2024

Veracyte to Participate in Upcoming Investor Conferences

Read More

Oct 16, 2024

Veracyte to Release Third Quarter 2024 Financial Results on November 6, 2024

Read More

Oct 02, 2024

New Data Presented at ASTRO 2024 Show that Veracyte’s Decipher Prostate Test Predicts Aggressive Prostate Cancer in African American Men

Read More

Sep 15, 2024

New Data Presented at ESMO 2024 Show that Veracyte’s Decipher Prostate Test Predicts Chemotherapy Benefit in Patients with Metastatic Prostate Cancer

Read More

Sep 04, 2024

Veracyte Appoints Brent Shafer and Tom Miller, Ph.D., to Its Board of Directors

Read More

Aug 26, 2024

Veracyte to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference

Read More

Aug 26, 2024

Veracyte Named a Greater Bay Area Top Workplace by the San Francisco Chronicle

Read More

Aug 06, 2024

Veracyte Announces Second Quarter 2024 Financial Results

Read More